BlockBeats news, on March 29, the US-listed Solana treasury company Artelo Biosciences announced that it would sell a total of 3,188,407 shares of common stock through a private placement at a price of $3.45 per share, raising a total of $11 million. The new funds will be used for general corporate purposes and to repay part of the transitional debt. Artelo currently holds 45,883 SOL.